Literature DB >> 11807990

Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability.

Hiroyuki Yamamoto1, Yongfen Min, Fumio Itoh, Arisa Imsumran, Shina Horiuchi, Mio Yoshida, Shouhei Iku, Hiroshi Fukushima, Kohzoh Imai.   

Abstract

High-frequency microsatellite instability (MSI-H) due to defective DNA mismatch repair occurs in the majority of hereditary nonpolyposis colorectal cancers (HNPCCs) and in a subset of sporadic malignant tumors. Clinicopathologic and genotypic features of MSI-H colorectal tumors in HNPCC patients and those in sporadic cases are very similar but not identical. Correlation between the MSI phenotype and aberrant DNA methylation has been highlighted recently. A strong association between MSI and CpG island methylation has been well characterized in sporadic colorectal cancers with MSI-H but not in those of hereditary origin. To address the issue, we analyzed hereditary and sporadic colorectal cancers for aberrant DNA methylation of target genes using methylation-specific polymerase chain reaction. DNA methylation of the MLH1, CDKN2A, MGMT, THBS1, RARB, APC, and p14ARF genes was found in 0%, 23%, 10%, 3%, 73%, 53%, and 33% of 30 MSI-H cancers in HNPCC patients and in 80%, 55%, 23%, 23%, 58%, 35%, and 50% of 40 sporadic colorectal cancers with MSI-H, respectively. Cases showing methylation at three or more loci of six genes other than MLH1 were defined as CpG island methylator phenotype-positive (CIMP +), and 23% of HNPCC tumors and 53% of sporadic cancers with MSI-H were CIMP+ (P = 0.018). Differences in the extent of CpG island methylation, coupled with the differential involvement of several genes by methylation, in HNPCC tumors and sporadic MSI-H colorectal cancers may be associated with diverging developmental pathways in hereditary and sporadic cancers despite similar MSI-H phenotypes. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11807990     DOI: 10.1002/gcc.10010

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  18 in total

1.  Clinicopathologic and molecular features of sporadic microsatellite- and chromosomal-stable colorectal cancers.

Authors:  Guoxiang Cai; Ye Xu; Hongfen Lu; Yingqiang Shi; Peng Lian; Junjie Peng; Xiang Du; Xiaoyan Zhou; Zuqing Guan; Daren Shi; Sanjun Cai
Journal:  Int J Colorectal Dis       Date:  2008-04       Impact factor: 2.571

2.  Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation.

Authors:  Hanifa Bouzourene; Pierre Hutter; Lorena Losi; Patricia Martin; Jean Benhattar
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

Review 3.  Microsatellite instability in gastrointestinal tract cancers: a brief update.

Authors:  Shinya Oda; Yan Zhao; Yoshihiko Maehara
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Mutation and methylation of hMLH1 in gastric carcinomas with microsatellite instability.

Authors:  Dian-Chun Fang; Rong-Quan Wang; Shi-Ming Yang; Jian-Ming Yang; Hai-Feng Liu; Gui-Yong Peng; Tian-Li Xiao; Yuan-Hui Luo
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.

Authors:  S Ogino; M Cantor; T Kawasaki; M Brahmandam; G J Kirkner; D J Weisenberger; M Campan; P W Laird; M Loda; C S Fuchs
Journal:  Gut       Date:  2006-01-11       Impact factor: 23.059

Review 6.  Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis.

Authors:  Zdenko Herceg; Pierre Hainaut
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

7.  Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.

Authors:  A McGivern; C V A Wynter; V L J Whitehall; T Kambara; K J Spring; M D Walsh; M A Barker; S Arnold; L A Simms; B A Leggett; J Young; J R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

8.  Mutations in both KRAS and BRAF may contribute to the methylator phenotype in colon cancer.

Authors:  Takeshi Nagasaka; Minoru Koi; Matthias Kloor; Johannes Gebert; Alex Vilkin; Naoshi Nishida; Sung Kwan Shin; Hiromi Sasamoto; Noriaki Tanaka; Nagahide Matsubara; C Richard Boland; Ajay Goel
Journal:  Gastroenterology       Date:  2008-03-08       Impact factor: 22.682

Review 9.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  CpG island methylation is a common finding in colorectal cancer cell lines.

Authors:  C M Suter; M Norrie; S L Ku; K F Cheong; I Tomlinson; R L Ward
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.